Delta-Omicron recombinant escapes therapeutic antibody neutralization
R. Duerr, H. Zhou, T. Tada, D. Dimartino, C. Marier, P. Zappile, G. Wang, J. Plitnick, S. Griesemer, R. C. Girardin, J. Machowski, S. Bialosuknia, E. Lasek-Nesselquist, S. L. Hong, G. Baele, , A. Heguy
This study identifies a Delta-Omicron recombinant SARS-CoV-2 variant that escapes Sotrovimab neutralization, highlighting the role of recombination in immune escape.
bioRxiv · Apr 6, 2022Microbiology